Back
BridgeBio Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
BBIO
BridgeBio Pharma, Inc.
Last Price:
$70.14
Seasonality Move:
3.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.1 | Buy |
| 20-day SMA: | 68.23 | Buy |
| 50-day SMA: | 72.71 | Sell |
| 200-day SMA: | 59.61 | Buy |
| 8-day EMA: | 50.18 | Buy |
| 20-day EMA: | 27.56 | Buy |
| 50-day EMA: | 12.68 | Buy |
| 200-day EMA: | 3.41 | Buy |
BridgeBio Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.32 | Buy |
| Relative Strength Index (14 RSI): | 50.1 | Buy |
| Chaikin Money Flow: | -849486 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.06 - 73.06) | Buy |
| Bollinger Bands (100): | (65.47 - 76.75) | Sell |
BridgeBio Pharma, Inc. Technical Analysis
| Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | Mar 12 | Mar 13 | Mar 16 | Mar 17 | Mar 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BridgeBio Pharma, Inc. Stock
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 70.12 while BBIO 8-day simple moving average is 70.10, which is a Buy signal.
-
The stock price of BBIO is 70.12 while BridgeBio Pharma, Inc. 20-day SMA is 68.23, which makes it a Buy.
-
BridgeBio Pharma, Inc. 50-day simple moving average is 72.71 while BBIO share price is 70.12, making it a Sell technically.
-
BBIO stock price is 70.12 and BridgeBio Pharma, Inc. 200-day simple moving average is 59.61, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
40
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. a Buy or a Sell?
-
BridgeBio Pharma, Inc. stock is rated a SellThe current BridgeBio Pharma, Inc. [BBIO] share price is $70.12. The Score for BBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma, Inc. Stock Info
Market Cap:
13.6B
Price in USD:
70.12
Share Volume:
1.4M
BridgeBio Pharma, Inc. 52-Week Range
52-Week High:
84.94
52-Week Low:
28.33
Sell
40
BridgeBio Pharma, Inc. (BBIO)
is a Sell
BridgeBio Pharma, Inc. Share Price Forecast
-
What is the BridgeBio Pharma, Inc. stock price today?The BridgeBio Pharma, Inc. stock price is 70.12 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma, Inc. is overvalued.
Is BridgeBio Pharma, Inc. Stock a Buy?
-
BridgeBio Pharma, Inc. share price is 70.12 while BBIO 8-day exponential moving average is 50.18, which is a Buy signal.
-
The stock price of BBIO is 70.12 while BridgeBio Pharma, Inc. 20-day EMA is 27.56, which makes it a Buy.
-
BridgeBio Pharma, Inc. 50-day exponential moving average is 12.68 while BBIO share price is 70.12, making it a Buy technically.
-
BBIO stock price is 70.12 and BridgeBio Pharma, Inc. 200-day simple moving average is 3.41, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma, Inc.
Is BridgeBio Pharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.
Technical Analysis of BridgeBio Pharma, Inc.
Should I short BridgeBio Pharma, Inc. stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 17.32, suggesting BridgeBio Pharma, Inc. is a Buy
-
BridgeBio Pharma, Inc. Relative Strength Index (RSI) is 50.1, which suggest BridgeBio Pharma, Inc. is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma, Inc. is (66.06 - 73.06), which suggest BridgeBio Pharma, Inc. is a Sell
-
The Bollinger Bands (100) for BridgeBio Pharma, Inc. is (65.47 - 76.75), which suggest BridgeBio Pharma, Inc. is a Sell
* BridgeBio Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.